Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
MicroPort CardioFlow Medtech Corporation, a medical device company, researches, develops, and commercializes transcatheter and surgical solutions for structural heart diseases in the People's Republic of China. It offers Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set to target aortic, mitral, tricuspid, and surgical valves, as well as procedural accessories. The company was...
Company Valuation
Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E.
Target Price
The average target price of 2160.HK is 1.8 and suggests 94% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell